Lungevity Foundation And Partner Hamoui Family Foundation Issue 2022 Request For Applications For Ret Positive Clinical Lung Cancer Research
WASHINGTON, Aug. 23, 2021 /PRNewswire/ — LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit organization, is partnering with The Hamoui Foundation to offer a new lung cancer research award program. The award supports research that will change RET-positive lung cancer into a chronic or curable condition. This will be transformative for the approximately 1%-2% of people with non-small cell lung cancer with the RET driver mutation. Funding for this award is being provided by The Hamoui Foundation, while LUNGevity will provide research infrastructure and scientific expertise....